BMRN Financial Facts
Net product revenues: 278.26MNET INCOME (LOSS) PER SHARE, DILUTED: -0.26
See Full Income Statement
Total liabilities: 1.2B
Total current assets: 1.67B
See Full Balance Sheet
BioMarin Pharmaceutical Inc. (BMRN) Earnings
|
Expand Research on BMRN
| Next EPS Date | 8/4/26 *Est. | EPS Growth Rate | -100.0% *Last Qtr. |
|---|---|---|---|
| Average EPS % Beat Rate | +86.2% | Revenue Growth Rate | -100.0% *Last Qtr. |
| Average % Move 1-Wk after EPS | -3.8% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
4/29/26  |
Q126 | N/A | $0.75 | N/A | N/A | $763.39M | = | N/A | N/A | ||
| 2/23/26 | Q425 | $0.46 | $0.77 | -$0.31 | $875M | $829.31M | = |  | | Details | |
| 10/27/25 | Q325 | $0.12 | -$0.08 | +$0.20 | $776M | $782.3M | = | | | Details | |
| 8/4/25 | Q225 | $1.44 | $0.83 | +$0.61 | $825M | $760.37M | = | | | Details | |
| 5/1/25 | Q125 | $1.13 | $0.70 | +$0.43 | $745M | $741.02M | = | | | Details | |
| 2/19/25 | Q424 | $0.92 | $0.55 | +$0.37 | $747M | $711.42M | = | | | Details | |
| 10/29/24 | Q324 | $0.91 | $0.53 | +$0.38 | $746M | $703.14M | = | | | Details | |
| 8/5/24 | Q224 | $0.96 | $0.35 | +$0.61 | $712M | $662.05M | = | | | Details |
